Location History:
- Cheshire, GB (2018 - 2020)
- Cambridge, GB (2022)
Company Filing History:
Years Active: 2018-2022
Title: The Innovations of Steven Christopher Glossop
Introduction
Steven Christopher Glossop is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of proliferative diseases. With a total of 4 patents to his name, Glossop's work has the potential to impact medical treatments significantly.
Latest Patents
Glossop's latest patents include innovative compounds known as [1,2,4]triazolo[4,3-b]pyridazines. These compounds are designed for use in the treatment of proliferative diseases. The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R, R, and n have specific meanings defined in the description. The processes for their preparation, pharmaceutical compositions containing them, and their use as anti-proliferative and/or cell-killing agents are also detailed in his patents.
Career Highlights
Glossop is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for complex health issues. His contributions to the field have been recognized through his patents, which reflect his commitment to advancing medical science.
Collaborations
Glossop has collaborated with esteemed colleagues such as Robert Hugh Bradbury and Alfred Arthur Rabow. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Steven Christopher Glossop's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his dedication to improving treatments for proliferative diseases. Through his efforts, he continues to make a meaningful impact in the field of medicine.